VeriSign Inc
VRSN
$270.90
-1.40%
VeriSign Inc. operates critical internet infrastructure as the exclusive registry operator for the .com and .net top-level domains (TLDs), a role within the domain name system (DNS) that is regulated by ICANN and the U.S. NTIA. The company is a pure-play, highly profitable monopoly-like entity in the Software - Infrastructure industry, generating recurring subscription revenue from domain registrations. The current investor narrative is dominated by the stock's recent price volatility and its defensive, cash-generative business model, with debates likely centered on its growth prospects given its mature core market, the implications of its upcoming regulatory contract renewals, and its aggressive capital return program through stock buybacks.…
VRSN
VeriSign Inc
$270.90
Investment Opinion: Should I buy VRSN Today?
Rating & Thesis: Hold. VRSN is a high-quality, defensive cash compounder trading at a fair valuation, but its low-growth profile and regulatory overhang limit near-term upside, making it suitable for income-focused portfolios rather than growth seekers. The sparse analyst sentiment leans slightly bullish, but the lack of a clear target price underscores the uncertainty. Supporting Evidence: The stock trades at a forward PE of 25.0x, which is in the middle of its historical range, suggesting it is fairly valued, not cheap. Revenue growth is steady but modest at 7.56% YoY. Profitability is exceptional, with net margins near 49%. The company generates massive free cash flow ($1.07B TTM) and returns nearly all of it to shareholders via buybacks and a small dividend (yield 0.96%). The implied valuation is a premium paid for stability and capital return, not for acceleration. Risks & Conditions: The two biggest risks are regulatory contract renewal uncertainty and further multiple compression if growth decelerates. This Hold rating would upgrade to a Buy if the forward PE compressed below 21x (approaching historical lows) on non-fundamental selling, or if the company secured a favorable long-term contract renewal with clear pricing power. It would downgrade to a Sell if quarterly revenue growth decelerated below 5% or if operating margins showed sustained contraction. The stock is currently fairly valued relative to its own history and growth prospects.
Sign up to view all
VRSN 12-Month Price Forecast
VRSN is a classic 'bond proxy' stock with equity characteristics: it offers stability, high cash generation, and shareholder returns but lacks growth catalysts. The investment thesis is currently in a holding pattern, awaiting clarity on the regulatory contract renewal. The recent price recovery from the lows suggests the worst of the multiple compression may be over, but significant upside requires a resolution of the regulatory overhang or a market environment that heavily favors defensives. The stance would turn bullish on a clear favorable regulatory outcome; it would turn bearish if growth decelerates or contract terms worsen.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on VeriSign Inc's 12-month outlook, with a consensus price target around $352.17 and implied upside of +30.0% versus the current price.
Average Target
$352.17
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$217 - $352
Analyst target range
Analyst coverage for VeriSign is very limited, with only 2 analysts providing estimates, indicating it is a niche stock with subdued institutional interest. The consensus sentiment from the sparse recent ratings (Citigroup 'Buy', JP Morgan 'Neutral', Baird 'Outperform') leans slightly bullish. Insufficient data is provided to calculate a meaningful average target price or implied upside/downside, which is a critical gap for investors. The extremely limited analyst coverage and lack of a published target price range signal high uncertainty and low visibility on future catalysts. For a company of VeriSign's market cap (~$22.9B), minimal coverage is unusual and often associated with a straightforward, slow-growth story that offers few surprises. This can lead to higher volatility due to less efficient price discovery and makes the stock more susceptible to sentiment shifts based on quarterly results or regulatory news. Investors must rely more heavily on their own fundamental and valuation work due to the lack of consensus analyst guidance.
Bulls vs Bears: VRSN Investment Factors
The bull case for VRSN rests on its defensive, cash-generative monopoly with exceptional margins and aggressive capital returns, which have supported a recent relief rally. The bear case highlights its mature, low-growth profile, regulatory risks, and severe market underperformance. Currently, the bearish evidence appears stronger, given the stock's significant downtrend, high valuation for its growth rate (PEG 2.66), and massive underperformance versus the market. The single most important tension is between the company's near-term defensive cash flows and its long-term growth ceiling; resolution depends on whether the market continues to pay a premium for stability or further de-rates the stock due to its lack of growth catalysts.
Bullish
- Exceptional Profitability and Margins: VeriSign's Q4 2025 net margin of 48.48% and gross margin of 88.48% are exceptionally high, indicating a highly efficient, asset-light monopoly business. This superior profitability underpins its premium valuation and generates massive free cash flow, with TTM FCF of $1.07 billion.
- Massive Capital Return Program: The company aggressively returns cash to shareholders, evidenced by $254.4M in stock repurchases and $71.1M in dividends paid in Q4 2025 alone. This buyback program, funded by predictable cash flows, provides a floor for the stock price and accretes value per share.
- Defensive Business with Low Beta: VRSN's beta of 0.695 confirms its defensive nature, being about 30% less volatile than the market. This was demonstrated in the past month, where the stock gained 10.38% while the S&P 500 fell 4.28%, showing its role as a haven during market stress.
- Recurring Revenue and Steady Growth: Revenue grew 7.56% YoY in Q4 2025 to $425.3M, showing consistent low-single-digit growth from a mature, annuity-like business model. The sequential quarterly growth from $402.3M in Q1 2025 demonstrates predictable, recurring subscription revenue from its .com/.net monopoly.
Bearish
- Mature, Low-Growth Business Model: Revenue growth is limited to mid-single digits (7.56% YoY in Q4), reflecting a saturated core market with no segment diversification. The PEG ratio of 2.66 indicates the stock is expensive relative to its modest growth prospects, trading at a forward PE of 25x.
- Regulatory Contract Renewal Risk: VeriSign's exclusive .com/.net registry contracts with ICANN and the U.S. NTIA are subject to renewal every six years. Any unfavorable changes in terms, pricing restrictions, or political scrutiny during renewal negotiations pose an existential threat to its business model and cash flows.
- Severe Underperformance vs. Market: The stock's 1-year price change of +1.70% significantly underperformed the S&P 500's +22.2% gain, a relative weakness of -20.5%. This reflects investor skepticism about its growth trajectory and a sector rotation away from low-growth, high-margin names.
- Extremely Limited Analyst Coverage: Only 2 analysts cover the stock, indicating low institutional interest and poor visibility on future catalysts. The lack of a published consensus target price creates higher uncertainty and less efficient price discovery, making the stock prone to sentiment-driven volatility.
VRSN Technical Analysis
The stock is in a pronounced downtrend over the observed 180-day period, with the price declining from above $270 in early October 2025 to a low near $211 in late February 2026, representing a 1-year price change of only +1.70% which significantly underperforms the S&P 500's +22.2% gain. As of the latest close of $259.85, the stock is trading at approximately 49% of its 52-week range ($208.86 to $310.60), indicating it is much closer to its yearly low than its high, which may suggest a value opportunity but also reflects persistent negative momentum and investor skepticism. The stock's beta of 0.695 confirms it has been a defensive, low-volatility holding relative to the broader market, though this has not protected it from a significant drawdown of -30.88% during this period. Recent momentum shows signs of a potential reversal or relief rally, with the stock posting a strong +10.38% gain over the past month and an +8.03% gain over the past three months, sharply contrasting with the S&P 500's declines of -4.28% and -4.0% over the same periods, respectively. This positive relative strength of +14.66% over one month indicates the stock is acting as a defensive haven or is oversold and bouncing, though it remains down -4.81% over the last six months. The divergence between the improving short-term momentum and the weak longer-term trend suggests the stock may be attempting to find a bottom after its steep decline from the October highs. Key technical support is firmly established at the 52-week low of $208.86, while major resistance lies at the 52-week high of $310.60. A sustained breakout above the recent recovery high near $260 would be needed to signal a more convincing trend reversal, while a breakdown below the $209 support could trigger another leg down. The stock's low beta of 0.695 implies it is about 30% less volatile than the market, which is typical for a stable, cash-flow generative business but also means rallies may be more muted; investors should size positions accordingly, understanding that while downside risk may be limited by valuation, explosive upside is also constrained by the company's low-growth profile.
Beta
0.69
0.69x market volatility
Max Drawdown
-30.9%
Largest decline past year
52-Week Range
$209-$311
Price range past year
Annual Return
+15.0%
Cumulative gain past year
| Period | VRSN Return | S&P 500 |
|---|---|---|
| 1m | +11.8% | -0.3% |
| 3m | +9.6% | -2.0% |
| 6m | +3.9% | +3.5% |
| 1y | +15.0% | +36.2% |
| ytd | +12.6% | -0.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
VRSN Fundamental Analysis
VeriSign's revenue exhibits steady, low-single-digit growth, with Q4 2025 revenue of $425.3 million representing a 7.56% year-over-year increase. Sequentially, revenue has grown from $402.3 million in Q1 2025 to $425.3 million in Q4 2025, demonstrating consistent quarterly expansion. The company's growth is entirely driven by its .com and .net registry operations, with no segment diversification; this trajectory reflects a mature, annuity-like business model where growth is tied to incremental domain base expansion and price increases, resulting in a predictable but non-accelerating top-line profile. The company is exceptionally profitable, with a Q4 2025 net income of $206.2 million and a net margin of 48.48%. Gross margins are stellar at 88.48% for the quarter, and operating margins are robust at 67.66%, reflecting the asset-light, high-margin nature of the registry business. Profitability has been stable, with net margins hovering around 49-51% across recent quarters, indicating highly efficient operations with minimal cost inflation. The company's net margin of 49.84% significantly exceeds typical software infrastructure peers, underpinning its premium valuation. VeriSign's financial health is characterized by massive cash generation and a strong but unusual balance sheet. The company generated $289.6 million in operating cash flow and $285.1 million in free cash flow in Q4 2025 alone, with TTM free cash flow of $1.07 billion. It aggressively returns capital to shareholders, evidenced by $254.4 million in stock repurchases and $71.1 million in dividends paid during the quarter. The debt-to-equity ratio is negative at -0.83 due to significant treasury stock from buybacks, which distorts traditional equity metrics; however, the company's interest coverage ratio of 15.07 and substantial cash balances indicate minimal financial risk. The current ratio of 0.49 appears low but is manageable given the predictable, high-margin cash flows.
Quarterly Revenue
$425300000.0B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.88%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is VRSN Overvalued?
Given the company's substantial net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. VeriSign trades at a trailing PE of 27.19x and a forward PE of 24.98x based on estimated EPS. The forward multiple being lower than the trailing multiple suggests analysts expect modest earnings growth, with the market pricing in a slight earnings acceleration or multiple compression. Compared to industry averages (data not available in the provided set), a precise sector comparison cannot be quantified. However, a trailing PE of 27.2x for a company with mid-single-digit revenue growth is typically at a premium to the broader market, justified by VeriSign's exceptional profitability metrics (e.g., 88% gross margin, 49% net margin), defensive cash flows, and monopolistic market position. The valuation premium reflects payment for quality, stability, and capital return, not high growth. Historically, the stock's own trailing PE has fluctuated significantly, ranging from lows near 19.8x in late 2023 to highs above 43.3x in mid-2021. The current PE of 27.2x sits roughly in the middle of this multi-year range, suggesting the market is neither excessively optimistic nor pessimistic. This mid-range historical valuation implies that much of the recent price decline has been a multiple contraction aligning with the slower growth outlook, rather than a pricing of fundamental deterioration.
PE
27.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 20x~43x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: VeriSign's primary financial risk is its complete revenue concentration in the .com and .net registry business, with no diversification. While its net margin of 48.5% and free cash flow generation of $1.07B TTM are stellar, the business model depends entirely on continued domain base growth and the ability to implement periodic price increases. Any stagnation in the domain name market or regulatory pushback on pricing would immediately pressure its low-single-digit revenue growth trajectory, which is already modest at 7.56% YoY. The company's negative debt-to-equity ratio (-0.83) due to aggressive buybacks distorts leverage metrics, but its interest coverage of 15.07 and predictable cash flows mitigate near-term solvency concerns. Market & Competitive Risks: The key market risk is valuation compression. Trading at a forward PE of 25x and a PEG ratio of 2.66, the stock carries a significant premium for its quality and stability. In a rising interest rate environment or a market rotation towards cyclical growth, this premium could contract further, as seen in its 30.9% drawdown. Its low beta of 0.695 offers defensive characteristics but also limits upside participation in bull markets. Competitive risks are low due to its government-contracted monopoly, but the existential threat is regulatory, not competitive. The stock's high short ratio of 2.55 indicates notable bearish sentiment betting on these risks materializing. Worst-Case Scenario: The worst-case scenario involves a 'perfect storm' where the upcoming ICANN/NTIA contract renewal imposes strict pricing caps or unfavorable terms, coinciding with a macroeconomic downturn that slows new domain registrations. This could halt revenue growth and compress margins, leading to multiple contraction towards its historical PE low of 19.8x. Combined with a broad market sell-off, this could drive the stock back to test its 52-week low of $208.86. From the current price of ~$259.85, this represents a realistic downside of approximately -20%. A breach of this support could trigger a further decline, though the company's massive buyback program would likely provide a partial floor.
FAQ
The key risks are: 1) Regulatory & Contractual: The renewal of its exclusive .com/.net registry agreements every six years poses an existential risk if terms become less favorable (most severe). 2) Growth: The business is mature, with revenue growth limited to ~7% YoY, offering limited upside surprise. 3) Valuation: Trading at a forward PE of 25x and a PEG of 2.66, the stock is vulnerable to multiple compression in a rising rate environment. 4) Market Sentiment: The stock has significantly underperformed the S&P 500 (-20.5% relative over 1 year) and has high short interest (ratio 2.55), reflecting bearish sentiment.
The 12-month forecast is range-bound with three scenarios. The base case (60% probability) sees the stock trading between $240 and $275, as steady execution and buybacks support a fair multiple. The bull case (25% probability) targets $285 to $310, driven by a favorable contract renewal and defensive market flows. The bear case (15% probability) risks a drop to $209-$235 on negative regulatory news or multiple compression. The base case is most likely, assuming the status quo of low growth and high cash returns persists. The key assumption is that contract renewal uncertainty does not materially worsen.
VRSN appears fairly valued. Its trailing PE of 27.2x and forward PE of 25.0x sit in the middle of its own multi-year historical range (19.8x to 43.3x). Compared to the broader market, this is a premium multiple, but it is justified by the company's exceptional net margin of 49.8% and defensive cash flows. The PEG ratio of 2.66, however, signals it is expensive relative to its growth rate. The valuation implies the market is paying for stability and quality, not for acceleration, and has already adjusted from previous optimism.
VRSN is a good buy for a specific type of investor: those seeking a defensive, low-volatility holding with reliable cash generation and capital return, not for those seeking high growth. With a forward PE of 25x, it is fairly valued, not cheap, offering modest implied upside from current levels. The biggest downside risk is regulatory, tied to its contract renewals. It is a good buy for income-focused, risk-averse portfolios that can tolerate low single-digit revenue growth, but investors should size positions acknowledging its binary regulatory overhang.
VRSN is primarily suitable for long-term investment as a defensive, income-generating holding. Its low beta (0.695) and reliable cash flows align with a multi-year horizon where compounding through buybacks can drive total return. It is less suitable for short-term trading due to its low volatility and lack of near-term explosive catalysts; the regulatory overhang creates binary event risk that could cause sharp moves, but timing these is difficult. A minimum holding period of 2-3 years is suggested to allow the capital return program to work and to navigate the contract renewal cycle.